Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-05-27
2009-02-03
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S580000, C540S586000
Reexamination Certificate
active
07485634
ABSTRACT:
Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.
REFERENCES:
patent: 3419569 (1968-12-01), Renner
patent: 3529062 (1970-09-01), Renner
patent: 4719208 (1988-01-01), Hannart et al.
patent: 6544984 (2003-04-01), Albright et al.
patent: 6586421 (2003-07-01), Frank et al.
patent: 6667304 (2003-12-01), Guillaumet et al.
patent: 2003/0225057 (2003-12-01), Smith et al.
patent: 2004/0054170 (2004-03-01), Jacobsen et al.
patent: 506543 (1971-06-01), None
patent: 64317 (1986-02-01), None
patent: 1180615 (1970-02-01), None
patent: 1180616 (1970-02-01), None
patent: WO 01/05793 (2001-01-01), None
Efange et al., Modified Ibogaine Fragments: Synthesis and Preliminary Pharmacological Characterization of 3-Ethyl-5-phenyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]benzothiophenes, J. of Medicinal Chemistry, Nov. 5, 1998, vol. 41, No. 23, pp. 4486-4491.
Pellicciari et al., Farnesoid X Receptor: From Structure to Potential Clinical Applications, Journal of Medicinal Chemistry, vol. 48, No. 17, pp. 5383-5403, Aug. 25, 2005.
Isomura et al., Firm Evidence For Cis-Aminopalladation in the Reaction of 1-Aminohexatrienes with Palladium Dichloride, Chemistry Letters, vol. 3, pp. 385-388, 1985.
Hatano et al., Palladium-Promoted Formation of Azepines From 1-Aminohexatrienyl System, Heterocycles, vol. 15, No. 2, pp. 747-752, 1981.
Lambert et al., The Farnesoid X-Receptor Is An Essential Regulator of Cholesterol Homeostasis, The Journal of Biological Chemistry, vol. 278, No. 4, pp. 2563-2570, 2003.
Asche, G. et al., “Synthesis of cyclic dipeptide templates, their incorporation into peptides and studies on their conformational and biological properties,”J. Peptide Res. 51: 323-336, 1998.
Beck, A. et al., “Synthesis of 3,4-Bridged Indoles by Photocyclisation Reactions. Part 1. Photocyclisation of Halogenoacetyl Tryptophan Derivatives,”J. Chem. Soc. Perkin Trans l: 797-811, 1992.
Bennasar, M.L. et al., “Formal Synthesis of the Indole Alkaloids Ngouniensine and Epingouniensine,”Heterocycles 29(2): 381-390, 1989.
Bennasar, M.L. et al., “Studies on the Synthesis of the Indole Alkaloids Ngouniensine and Epingouniensine,”Tetrahedron 47(29): 5507-5512, 1991.
Bosch, J. et al., “Total Synthesis of the Indole Alkaloids. Ngouniensine and Epingouniensine,”Tetrahedron Letters 28(2): 231-234, 1987.
Brown and Garrison, “Derivatives of Indole, 6-Amino-3-indoleacetic Acid,”Journal of the American Chemical Society 77: 3839-3842, Jul. 1955.
Cox and Cook, “The Pictet-Spengler Condensation: A new Direction for an Old Reaction,”Chem. Rev. 95: 1797-1842, 1995.
Curphey, T., “Thionation with the Reagent Combination of Phosphorus Pentasulfide and Hexamethyldisiloxane,”J. Org. Chem. 67: 6461-6473, 2002.
Danieli, B. et al., “Asidosperma Alkaloids via Cyclization of Secodine Intermediate: Synthesis of (±)-3-Oxovincadifformine Ethyl Ester,”Tetrahedron 50(23): 6941-6954, 1994.
Elliott, A. et al., “Synthesis of Some 5-Phenylhexahydroazepino[4,5-b]indoles as Potential Neuroleptic Agents,”J. Med. Chem. 23(11):1268-1269, 1980.
Esser, F. et al., “Synthesis of a new didpeptide template, its X-ray structure, and modeling studies on its conformational features,”Int. J. Peptide Protein Res. 45: 540-546, 1995.
Gussio, R. et al., “Structure-based design modifications of the paullone molecular scaffold for cylin-dependent kinase inhibition,”Anti-Cancer Drug Design 15: 53-66, 2000.
Hugel, G. et al., “Flow Thermolysis Rearrangements in the Indole Alkaloid Series: Strictamine and Akuammicine Derivatives. The Absolute Configurations of Ngouniensine andepi-Ngouniensine,”J. Org. Chem. 62(3): 578-583, 1997.
Ibrahim, E. et al., “Synthesis of indolo[3,2-c]quinolines and indolo[3,2-d]benzazepines and their interaction with DNA,”Eur. J. Med. Chem. 23: 183-188, 1988.
Kaoudi, T. et al., “An Easy Entry into Berbane and Alloyohimbane Alkaloids via a 6-exoRadical Cyclization,”Organic Letters 3(20): 3125-3127, 2001.
Kaoudi, T. et al., “An Expedient Construction of Seven-Membered Rings Adjoining Aromatic Systems,”Angew. Chem. Int. Ed. 39(4): 731-733, 2000.
Khandelwal, Y. et al., “Synthesis and biological evaluation of 2-substituted 1,2,3,4,6,7,13,13a-octahydro-pyrazino[1′2′:1,2]azepino[5,4-b]indoles: A novel class of heterocyclic compounds,”Indian Journal of Chemistry 29B: 197-199, Feb. 1990.
Khandelwal, Y. et al., “Synthesis of 2-substituted 1,2,3,4,6,7,13,13a-octahydropyrazino (1′2′:1,2)azepiino[4,5-b]indoles: A new class of antihypertensive agents,”Indian Journal of Chemistry 28B: 475-478, Jun. 1989.
Koh, H.L. et al., “Conformational and structural features determining in vitro antimalarial activity in some indolo [3,2-c]quinolines, anilinoquinolines and tetrahydroindolo[3,2-d]benzazepines,”Eur. J. Med. Chem. 29: 107-113, 1994.
Koh, H.L. et al., “Molecular Geometry and Physicochemical Characteristics of Selected Anilinoquinolines, Indolo[3,2-c]quinolines and Tetrahydroindolo[3,2-d]benzazepines,”Chem. Pharm Bull 42(5): 1084-1087, May 1994.
Kozikowski, A. et al., Synthese von (2-Arylindol-3-yl)acetamiden als Sonden zur Untersuchung der mitochondrialen Steroidbildung—ein neuer Mechansims für die GABAA-Rezeptormodulation,Angew. Chem. 104(8): 1092-1094, 1992.
Kraxner, J. et al., “Azepino- and Diazepinoindoles: Synthesis and Dopamine Receptor Binding Profiles,”Arch. Pharm. Pharm. Med. Chem.333: 287-292, 2000.
Kuehne and Xu, “Syntheses of Strychnan- and Aspidospermatan-Type Alkaloids. 9. The Enantioselective Generation of Tetracyclic ABCE Intermediates by a Tandem Condensation, [3,3]-Sigmatropic Rearrangement, and Cyclization Sequence,”J. Org. Chem 62(23): 7950-7960, 1997.
Kuehne, M. et al., “Biomimetic Syntheses of Indole Alkaloids. 11. Syntheses of β-Carboline and Indoloazepine Intermediates,”Journal of Organic Chemistry 50(7): 919-924, Apr. 1985.
Kuehne, M. et al., “Formation of D-Nor Aspidosperma Alkaloids by Condensation ofNb-Benzylindoloazepine with Aldehydes,”J. Org. Chem.58(15): 4147-4148, 1993.
Kuehne, M. et al., “Studies in Biomimetic Alkaloid Syntheses. 13. Total Syntheses of Racemic Aspidofractine, Pleiocarpine, Pleiocarpinine, Kopsinine,N-Methylkopsanone, and Kopsanone,”J. Org. Chem. 50: 4790-4796, 1985.
Kunick, C., “Synthese von 7,12-Dihydro-indolo[3,2-d][1]benzazepin-6-(5H)-onen und 6,11-Dihydro-thieno-[3′,2′:2,3]azepino[4,5-b]indol-5(4H)-on,” Arch. Pharm.(Weinheim) 325: 297-299, 1992.
Kutney, J. et al., “Total Synthesis of Indole and Dihydroindole Alkaloids. IX) Studies on the Synthesis of Bisindole Alkaloids in the Vinblastine-Vincristine Series. The Biogenetic Approach,”Helvetica Chimica Acta 59(8): 2858-5882, 1976.
Lam, P. et al., “Copper-catalyzed general C—N and C—O bond cross-coupling with arylboronic acid,”Tetrahedron Letters 42:3415-3418, 2001.
Maercker, A., “The Wittig Reaction,” inOrganic Reactions, vol. 14, Arthur C. Cope (ed), John Wiley & Sons, Jan. 1965, pp. 270-490.
Mahboobi and Bernauer, “Synthesis of Esters of 3-(2-Aminoethyl)-1H-indole-2 acetic acid and 3-(2-Aminoethyl)-1H-indole-2-malonic acid (=2-[3-(2-Aminoethyl)-1H-indol-2-yl]propanedioic acid),”Helvetica Chimica Acta 71: 2034-2041, 1988.
Mascal, M. et al., “Synthesis of (-)-Indolactam V,”J. Chem. Soc. Perkin Trans 1: 823-830, 1992.
Miyaura and Suzuki, “Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds,”Chem. Rev. 95(7): 2457-2483, 1995.
Mor, M. et al., &#x
Flatt Brenton T
Griffith Ronald
Gu Xiao-Hui
Martin Richard
Wang Tie-Lin
Coleman Brenda L
Exelixis Inc.
McDonnell Boehnen & Hulbert & Berghoff LLP
LandOfFree
Azepinoindole and pyridoindole derivatives as pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azepinoindole and pyridoindole derivatives as pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azepinoindole and pyridoindole derivatives as pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4114453